Kenneth J. Hillan - Feb 20, 2023 Form 4 Insider Report for 23andMe Holding Co. (ME)

Role
Chief Therapeutics Officer
Signature
/s/ Kenneth Hillan, by Kathy Hibbs, attorney-in-fact
Stock symbol
ME
Transactions as of
Feb 20, 2023
Transactions value $
-$15,662
Form type
4
Date filed
2/22/2023, 04:12 PM
Previous filing
Dec 23, 2022
Next filing
May 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ME Class A Common Stock Tax liability -$15.7K -5.46K -2.77% $2.87 192K Feb 20, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The closing price on February 17, 2023, the fair market used for the transaction date.